Noveltreat 1.7 mg Pre-filled Pen | Wholesale Semaglutide Exporter from India — Ernest Impex
Description
Noveltreat 1.7 mg Pre-filled Pen: High-Potency Maintenance Therapy for Weight Loss
Are you seeking a trusted Noveltreat 1.7 mg Pre-filled Pen exporter from India? Ernest Impex, a key member of the Group of Ernest Pharmaceutical Pvt. Ltd., is a global specialist in the wholesale distribution of advanced GLP-1 receptor agonists. We provide robust, GDP-compliant supply chains and secure pharmaceutical logistics to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica).
Extensive Product Profile: Understanding Noveltreat 1.7 mg
Noveltreat 1.7 mg Pre-filled Pen contains Semaglutide, a potent metabolic regulator manufactured by Sun Pharmaceutical Industries Ltd. As an advanced maintenance strength, the 1.7 mg dose is designed for patients who require intensive support for long-term weight maintenance and cardiovascular risk reduction after completing lower-dose titration phases.
1. Clinical Indications & Usage
Chronic Weight Management: Indicated for long-term weight loss and maintenance in adults with obesity (BMI $ge$ 30 $kg/m^2$) or overweight (BMI $ge$ 27 $kg/m^2$) with weight-related comorbidities.
Adolescent Obesity: Specifically approved for adolescents aged 12 years and older with a high initial BMI.
Cardiovascular Protection: Clinically used to reduce the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or death in adults with established heart disease and high BMI.
Liver Health: Emerging evidence supports its use in treating non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring.
2. Mechanism of Action: The GLP-1 Pathway
Appetite Regulation: It mimics a natural hormone that targets the hypothalamus in the brain, increasing feelings of fullness and significantly curbing food cravings.
Slowed Digestion: It slows down gastric emptying, leading to prolonged satiety and more stable blood sugar levels after meals.
Insulin Response: It stimulates the pancreas to release insulin in a glucose-dependent manner, while simultaneously reducing the liver's production of excess sugar.
3. Administration and Dosing Dose: Injected once weekly on the same day each week.
Escalation Path: This 1.7 mg strength is typically reached after sequential 4-week periods on 0.25 mg, 0.5 mg, and 1.0 mg doses.
Route: Subcutaneous injection in the abdomen, thigh, or upper arm.
Storage, Handling, and Stability Protocols
Primary Storage: Unused pens must be stored in a refrigerator between $2^circtext{C}$ and $8^circtext{C}$.
Stability After Use: Once the pen is first used, it can be kept at room temperature (below $30^circtext{C}$) or in the refrigerator for up to 56 days.
Light Protection: Keep the pen cap on to shield the medication from light exposure.Safety Warning: Do not freeze. If the solution becomes frozen, it is denatured and must be discarded.
Documentation & Global Export Compliance
Commercial Invoice
Certificate of Analysis (COA)
Bill of Lading / Airway Bill
Export License & Regulatory Support: We facilitate document clearance for TGA, HSA, US-FDA, and MHRA import requirements.
PRESCRIPTION MEDICINE IS: YES
Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions.
📞 Contact Ernest Impex — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
🌐 Websites:
www.ernestimpex.com
www.ernestvision.com
www.oncologymedicinesupplier.com
www.ernestpharmaceuticals.com
📧 Email: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
📲 WhatsApp Link: https://wa.me/919359902383
